Overview
Doe Labs delivers an enterprise AI platform for private-equity-backed healthcare groups, starting with Dental Service Organizations (DSOs). The platform uses task-specific AI agents that connect to fragmented systems, including practice-management software, supplier portals, and email, even when no formal APIs exist. These agents automate operations such as procurement, inventory optimization, approvals, scheduling, compliance, and analytics, enabling real-time visibility into profitability across multiple locations. By surfacing actionable insights and enabling cross-location automation, the system aims to lift EBITDA and operational efficiency for multi-site healthcare networks. The software-as-a-service model targets DSOs and other multi-site groups in healthcare segments like veterinary, ophthalmology, and med spas, focusing on the needs of private-equity-backed organizations that manage several sites.
Work here?Claim your company
Simplify's Take
What believers are saying
- 2026-01-21 launch promised up to 90% less office work.
- 2026-10-03 status page showed 90-day uptime above 99.7%.
- Y Combinator backing and 2025 launch strengthen hiring and customer credibility.
What critics are saying
- 2026-10-02 status showed AWS Bedrock errors and Doe backend issues.
- Public evidence shows limited access only; product-market traction remains unproven beyond launch.
- If model or connector reliability breaks, Doe cannot execute core workflows for customers.
What makes Doe Labs unique
- 2025 YC launch: Doe embeds agents into fragmented DSO systems without formal APIs.
- Doe automates procurement, approvals, scheduling, compliance, and analytics across healthcare operators.
- Doe gives CFOs real-time profitability visibility across locations, not just workflow automation.
Help us improve and share your feedback! Did you find this helpful?
Funding
Industry standards